Literature DB >> 23710602

Targeting innate immunity: a new step in the development of combination therapy for chronic hepatitis B.

Fabien Zoulim, Souphalone Luangsay, David Durantel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23710602     DOI： 10.1053/j.gastro.2013.04.028

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  8 in total

Review 1.  Present and future therapies of hepatitis B: From discovery to cure.

Authors:  T Jake Liang; Timothy M Block; Brian J McMahon; Marc G Ghany; Stephan Urban; Ju-Tao Guo; Stephen Locarnini; Fabien Zoulim; Kyong-Mi Chang; Anna S Lok
Journal:  Hepatology       Date:  2015-10-27       Impact factor: 17.425

Review 2.  Hepatitis B: Working Towards a Cure.

Authors:  Bianca W Chang; Aung Kaung; Lori Robbins; Tram T Tran
Journal:  Curr Gastroenterol Rep       Date:  2015-09

Review 3.  Antiviral therapies and prospects for a cure of chronic hepatitis B.

Authors:  Fabien Zoulim; David Durantel
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

4.  Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Authors:  S K Sarin; M Kumar; G K Lau; Z Abbas; H L Y Chan; C J Chen; D S Chen; H L Chen; P J Chen; R N Chien; A K Dokmeci; Ed Gane; J L Hou; W Jafri; J Jia; J H Kim; C L Lai; H C Lee; S G Lim; C J Liu; S Locarnini; M Al Mahtab; R Mohamed; M Omata; J Park; T Piratvisuth; B C Sharma; J Sollano; F S Wang; L Wei; M F Yuen; S S Zheng; J H Kao
Journal:  Hepatol Int       Date:  2015-11-13       Impact factor: 6.047

5.  The human C-type lectin 18 is a potential biomarker in patients with chronic hepatitis B virus infection.

Authors:  Tsung-Yu Tsai; Cheng-Yuan Peng; Hwai-I Yang; Ya-Lang Huang; Mi-Hua Tao; Shin-Sheng Yuan; Hsueh-Chou Lai; Shie-Liang Hsieh
Journal:  J Biomed Sci       Date:  2018-07-28       Impact factor: 8.410

Review 6.  Immunotherapy for Chronic Hepatitis B Virus Infection.

Authors:  Antonio Bertoletti; Nina Le Bert
Journal:  Gut Liver       Date:  2018-09-15       Impact factor: 4.519

Review 7.  Immune therapies against chronic hepatitis B.

Authors:  Sheikh Mohammad Fazle Akbar; Osamu Yoshida; Yoichi Hiasa
Journal:  J Gastroenterol       Date:  2022-06-16       Impact factor: 6.772

Review 8.  Hepatitis B: future curative strategies.

Authors:  Antonio Bertoletti; Laura Rivino
Journal:  Curr Opin Infect Dis       Date:  2014-12       Impact factor: 4.915
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.